Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ZELTIQ Aesthetics Inc's CoolSculpting receives FDA clearance


Monday, 14 Apr 2014 08:30am EDT 

ZELTIQ Aesthetics Inc:CoolSculpting procedure has received US FDA clearance to treat thighs with its entire suite of applicators.CoolSculpting procedure is clinically proven to non-surgically reduce unwanted fat, and is already FDA cleared to treat the abdomen and flanks. 

Company Quote

19.64
-0.68 -3.35%
12:23pm EDT